Holen Sie sich die Stockscreener-App
160.97
3.15%
-5.24
Handel nachbörslich:
160.30
-0.67
-0.42%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$166.21
Offen:
$167.845
24-Stunden-Volumen:
1.50M
Relative Volume:
0.91
Marktkapitalisierung:
$24.35B
Einnahmen:
$4.39B
Nettoeinkommen (Verlust:
$853.00M
KGV:
29.22
EPS:
5.5097
Netto-Cashflow:
$556.00M
1W Leistung:
-0.83%
1M Leistung:
+10.48%
6M Leistung:
+19.35%
1J Leistung:
+82.65%
1-Tages-Spanne:
$159.34
$168.00
1-Wochen-Bereich:
$155.55
$168.00
52-Wochen-Spanne:
$85.77
$177.22
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
160.97 | 24.35B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
469.34 | 174.42B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.10 | 127.47B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.88 | 44.24B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
129.84 | 36.67B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.53 | 34.91B | 3.77B | 449.25M | 240.68M | 7.8556 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. Stock (US4523271090): shares steady as investors await next earnings catalyst - AD HOC NEWS
Liquidity Mapping Around (ILMN) Price Events - Stock Traders Daily
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Inc (ILMN) Stock Down 3.1% but Still Overvalued -- GF S - GuruFocus
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
When sequencing isn’t enough: A global forum for finding answers - Illumina
Illumina Stock’s Operating Margin Climbs to 22% in Q1 2026: Is it Enough to Support a $300 Target? - TIKR.com
Fox Run Management L.L.C. Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Loomis Sayles Growth Portfolio's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina stock upgraded at J.P. Morgan (ILMN:NASDAQ) - Seeking Alpha
Illumina (NASDAQ:ILMN) Shares Gap Up After Analyst Upgrade - MarketBeat
JPMorgan Upgrades Illumina to Overweight From Neutral, Price Target is $185 - marketscreener.com
Amova Asset Management Americas Inc. Reduces Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina SVP Patricia Leckman sells $127,304 in company stock - Investing.com UK
Illumina SVP Patricia Leckman sells $127,304 in company stock By Investing.com - Investing.com South Africa
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN): Bullish Structure Builds After Breakout - FXEmpire
Illumina (ILMN) Chief People Officer sells 783 common shares - Stock Titan
Illumina Inc. stock (US4523271090): new StrataMap launch after strong 12?month rally - AD HOC NEWS
Templeton Global Smaller Companies Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina launches StrataMap Spatial Solution, a powerful end-to- - GuruFocus
8 Cancer organizations receive grants to expand access to genomic testing - Illumina
Illumina Launches StrataMap Spatial Solution for Whole Transcriptome Analysis - geneonline.com
Illumina launches StrataMap Spatial research solution By Investing.com - Investing.com Canada
Illumina launches StrataMap Spatial research solution - Investing.com
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution - PR Newswire
Why Grail Could Be the Sleeper Stock Everyone's About to Notice - The Motley Fool
Capital International Inc. CA Boosts Stock Position in Illumina, Inc. $ILMN - MarketBeat
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina (ILMN) Valuation Check After New Oncology Collaborations And MRD Research Launch - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Capital International Ltd. CA - MarketBeat
Capital World Investors Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Capital International Sarl Sells 15,683 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Illumina (Nasdaq: ILMN) Form 144 lists proposed sale by trust - Stock Titan
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) chief people officer sells 784 shares in open market - Stock Titan
What is multiomics? A simple guide to the future of biology - Illumina
Illumina, Inc. (NASDAQ:ILMN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Illumina Inc. stock (US4523271090): shares edge higher on Nasdaq amid focus on sequencing demand and - AD HOC NEWS
Illumina jumps as bullish analyst note extends optimism around clinical sequencing momentum - Quiver Quantitative
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina, Inc. Hits New 52-Week High of $165.93, Up 54% - Markets Mojo
Illumina, Inc. Hits New 52-Week High at USD 165.37 - Markets Mojo
Illumina, Inc. Hits New 52-Week High of $158.78, Up 48.7% - Markets Mojo
[144] ILLUMINA, INC. SEC Filing - Stock Titan
Frances Arnold reports proposed sale of 5,000 shares | ILMN SEC FilingForm 144 - Stock Titan
IDT partners with Illumina on oncology research workflow - Investing.com UK
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):